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Abstract: Allicin (diallylthiosulfinate) is a defence molecule from garlic (Allium sativum L.) 
with a broad range of biological activities. Allicin is produced upon tissue damage from the 
non-proteinogenic amino acid alliin (S-allylcysteine sulfoxide) in a reaction that is 
catalyzed by the enzyme alliinase. Current understanding of the allicin biosynthetic 
pathway will be presented in this review. Being a thiosulfinate, allicin is a reactive sulfur 
species (RSS) and undergoes a redox-reaction with thiol groups in glutathione and proteins 
that is thought to be essential for its biological activity. Allicin is physiologically active in 
microbial, plant and mammalian cells. In a dose-dependent manner allicin can inhibit the 
proliferation of both bacteria and fungi or kill cells outright, including antibiotic-resistant 
strains like methicillin-resistant Staphylococcus aureus (MRSA). Furthermore, in 
mammalian cell lines, including cancer cells, allicin induces cell-death and inhibits cell 
proliferation. In plants allicin inhibits seed germination and attenuates root-development. 
The majority of allicin’s effects are believed to be mediated via redox-dependent 
mechanisms. In sub-lethal concentrations, allicin has a variety of health-promoting 
properties, for example cholesterol- and blood pressure-lowering effects that are 
advantageous for the cardio-vascular system. Clearly, allicin has wide-ranging and 
interesting applications in medicine and (green) agriculture, hence the detailed discussion 
of its enormous potential in this review. Taken together, allicin is a fascinating biologically 
active compound whose properties are a direct consequence of the molecule’s chemistry.  
Keywords: garlic (Allium sativum); reactive sulfur species; apoptosis; redox; antimicrobial; 
cancer; root growth 
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1. Introduction 
Allicin, a sulfur-containing natural compound with many different biological properties is 
responsible for the typical smell and taste of freshly cut or crushed garlic. The general, though not 
entirely accurate, perception of natural products as mild and largely harmless in comparison to their 
chemically synthesized counterparts, has been suggested as one of the reasons for their growing 
preference by consumers, as well as their increasingly popular use in medicine and agriculture [1]. 
While the pharmaceutical industry in recent decades has largely focused on high-throughput 
biochemical screening programmes for the discovery and development of new drugs, the use of natural 
products for medicinal and antimicrobial purposes is an ancient practice [2]. For instance, the oldest 
medical resource available contains evidence of the prophylactic and therapeutic use of hundreds of 
plants and plant products [3]. Written on tablets of clay in cuneiform ca. 2600 BC, this ancient 
Mesopotamian compendium includes prescriptions for the use of Papaver somniferum (poppy juice), 
Glycyrrhiza glabra (liquorice), Cedrus species etc. for the treatment of common ailments and parasitic 
infections. Other ancient texts like the Egyptian Codex Ebers (Ebers Papyrus), the Greek “magical 
papyra” and the Chinese Materia Medica are also replete with records of the use of plants and plant 
extracts in medicine [3,4]. While the Ebers Papyrus and the “magical papyri” precisely mention the use 
of extracts from garlic for medicinal purposes, Virgil, the first century BC Roman poet, highlighted 
their use in treating snake bites in his Second Idyll [5], and the famous Greek physician, Hippocrates, 
described their efficacy in treating pneumonia and in wound healing in his Corpus Hippocraticum [6]. 
Although onions are the most widely used Allium and one of the world’s most consumed foods [4], it 
is their more pungent relative garlic, widely notorious for its rather feisty interaction with man’s 
olfactory receptors, that has received greater attention from investigators. From its various uses as a 
vampire repellent and an antidote for dog bites in older times, to its more recent perinatal recruitment 
by Greek midwives for the purpose of warding off “the evil eye” in labour rooms [4], garlic’s journey 
through time and history is as rich as it is colourful. Speculations abound concerning the origin of the 
cultivation of Allium—The genus to which garlic (Allium sativum), leek (A. porrum), onion (A. cepa), 
chives (A. schoenoprasum) and well over 700 other species belong, but there are early documented 
reports from Afghanistan, Kazakhstan, Kyrgyzstan, Pakistan, Tajikistan, Turkmenistan, Uzbekistan, 
and Northern Iran [7,8]. While garlic’s culinary, therapeutic and even spiritual value has been 
recognized and acknowledged for centuries, it was not until 1944 when Cavallito and Bailey [9] 
isolated and described the properties of allicin, the compound responsible for garlic's characteristic 
pungent odour, that researchers gained a clearer insight into the chemical wonder carefully packaged 
by nature in the composite bulbs of this edible Allium, and thus began decades of extensive research 
on allicin, “the heart of garlic” [10]. 
2. Biosynthesis of Allicin 
Allicin is a thiosulfinate, and its structure was determined by Stoll and Seebeck in 1948 [11]. In 
nature allicin is produced after damage of the plant tissue by an enzymatic reaction. The precursor of 
allicin is the non-proteinogenic amino acid alliin (S-allyl-L-cysteine sulfoxide) [12]. Alliin and other  
S-alkyl-L-cysteine sulfoxides are hydrolysed by the enzyme alliinase [13,14], and in the case of alliin 
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this reaction leads to production of dehydroalanine and allyl sulfenic acid. Two molecules of allyl 
sulfenic acid condense spontaneously to one molecule of allicin [15]. Alliin is found in garlic  
(Allium sativum) and ramsons (Allium ursinum) [11]. Interestingly, onion (Allium cepa) does not 
synthesize alliin, but its isomer isoalliin (trans-(+)-S-(1-propenyl)-L-cysteine sulfoxide) [16]. The 
biosynthetic route to alliin is still not clear. Pioneering work by Granroth [13], who reported two 
possible biosynthetic pathways based on radioactive labeling experiments, has up to now not been 
bettered. His findings are shown in Scheme 1. 
Scheme 1. Biosynthesis of allicin: Based on Granroth’s work there are two possible 
biosynthetic pathways leading to S-allyl-cysteine. The detection of 14C-labeled S-allyl-cysteine 
after feeding plants with 14C-labeled serine and the incorporation of various alkyl 
mercaptans led Granroth to the conclusion that serine is one possible substrate for  
S-allyl-cysteine biosynthesis. An alternative pathway leads from glutathione to  
S-allyl-cysteine. This was confirmed by the detection of S-allyl-glutathione and  
S-allyl-γ-glutamyl-cysteine. The source of the allyl-group is still unknown. S-allyl-cysteine 
is oxidised to alliin, which is the “inactive” precursor of allicin. Alliin is enzymatically 
hydrolysed to produce allyl sulfenic acid which condenses spontaneously to allicin. 
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In particular determining the origin of the double bond in alliin is problematic. Granroth was able to 
show that the double bond in isoalliin originated from methacrylic acid, but this was not the case for 
alliin, so the source of alliin’s double bond remains unknown. Furthermore, Granroth showed that 
onion is able to produce alliin when fed with allyl mercaptan or boiled garlic extract. Granroth also 
showed that not only cysteine but also serine can be a source of the amino acid part of alliin. This was 
achieved by feeding onion with 14C-labeled serine and a variety of thiols. In each case Granroth 
reported a 14C-labeled S-alkyl-L-cysteine sulfoxide, with the alkyl group corresponding to the supplied 
thiol. In the laboratory allicin can by synthesized by oxidation of diallyl disulfide (DADS) with 
hydrogen peroxide [17], magnesium monoperoxyphthalate [18] or chloroperbenzoic acid [19]. The 
oxidation of DADS by hydrogen peroxide is shown in Scheme 2 and reviewed by Ilić et al. [15]. 
Scheme 2. Synthesis of allicin according to Stoll and Seebeck: (A) Diallyl disulfide 
(distilled under reduced pressure) is mixed with acetic acid and hydrogen peroxide. 
Because hydrogen peroxide reacts very slowly with diallyl disulfide, acetic acid is needed 
as a catalyst. Peracetic acid (ethaneperoxoic acid) is formed, which is able to oxidize 
diallyl disulfide to allyl sulfenic acid. This reaction also leads to the production of allyl 
radicals which can react with hydrogen peroxide to form allyl sulfenic acid and hydroxyl 
radicals. The latter are able to react with diallyl disulfide to form allyl sulfenic acid and 
allyl radicals again. Two molecules of allyl sulfenic acid condense to allicin. This reaction 
mechanism is not only suitable to synthesize allicin but also other thiosulfinates. (B) To 
produce allicin by an enzymatic reaction alliin is needed. Cysteine is mixed with allyl 
bromide in an alkaline (NaOH) mixture of water and ethanol to obtain S-allyl cysteine. The 
latter can be oxidized with hydrogen peroxide to produce alliin. By an enzymatic reaction 
of alliin with alliinase, allicin is formed. 
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Further to the chemical synthesis of allicin, protocols for its enzymatic production in vitro have 
been published [20,21]. The substrate alliin can be extracted from garlic gloves or synthesized from 
cysteine by alkylation with allyl bromide followed by oxidation with hydrogen peroxide [11,14]. 
Because of allicin’s high reactivity and low thermal stability it is difficult to obtain and store pure 
allicin without contamination by related compounds like ajoene, vinyldithiine or polysulfane [22]. 
Nevertheless, in dilute aqueous solutions at −70 °C preparations have been reported to be stable over 
years (no loss in two years) [5]. 
3. Redox-Chemistry Pertaining to Allicin 
Subcellular compartments need to have regulated but individually diverse conditions to maintain 
biochemical cellular processes for metabolism. Thus, ionic concentration, pH and an appropriate redox 
potential need to be carefully maintained. Redox reactions are common in cells and can be recognized 
because the formal redox state of the atoms in the reactants changes. The concept of redox potential is 
an aspect of Thermodynamics and the local redox potential will determine whether a particular redox 
reaction is possible and in which direction a reversible redox reaction can proceed and what 
equilibrium point it might reach [23,24]. In a biological context many reactions are occurring 
simultaneously and are present in integrated networks. Thus, although thermodynamic concepts inform 
us about the possibility, direction and extent of a particular reaction, the picture is incomplete without 
a consideration of the relative rates of networked reactions, i.e., the Kinetics. For example, a given 
redox reaction may not be in equilibrium with the redox environment in the cellular compartment 
because one of the products is rapidly further metabolized or an enzyme catalyzing the reverse reaction 
proceeds very rapidly whereas the initial reaction is very slow [25]. Nevertheless, the global redox 
potential in a cellular compartment will influence the reactivity of accessible redox-active cellular 
metabolites and by this will affect the cell’s chemistry. 
In general, healthy cells have a negative cytosolic redox potential—that means the cytosol is in a 
reduced/reducing state. The cytosolic redox potential of baker’s yeast (Saccharomyces cerevisiae) is 
quoted with values between −220 mV and −320 mV [26]. The cellular redox potential is controlled 
largely by the GSH/GSSG redox couple (glutathione pool), along with the NAD(P)H/NAD(P)+ 
couples and thioredoxins. Glutathione is a tripeptide consisting of glutamic acid, cysteine and glycine. 
It was first found by Rey-Pailhade as a biological substance with reducing properties, when he used 
cell extracts to reduce sulfur to hydrogen sulfide. He named it philothione [27]. Glutathione got its 
present name from Frederick Hopkins, who, however, thought it to be a dipeptide of glutamic acid and 
cysteine [28]. Glutathione’s structure was solved by Harington and Mead in 1935 [29]. In cells GSSG 
is reduced to GSH by glutathione reductase (GR) and NADPH [30,31]. GR is a key enzyme in cellular 
redox homoeostasis [32,33]. 
Allicin is a reactive sulfur species (RSS) [23] with oxidizing properties, and it is able to oxidize 
thiols in cells, e.g., glutathione and cysteine residues in proteins. A more oxidized glutathione pool 
leads to a higher cellular redox potential. Oxidation of protein thiols can lead to changes in protein 
structure, for example through disulfide bond formation (for details see Scheme 3). Redox-triggered 
structural changes in proteins can lead to loss or gain of function. Such effects are already known for 
the plant protein NPR1, which is a key protein in pathogen-triggered immunity [34] and in yeast  
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(S. cerevisiae) for YAP1, which is a redox-sensitive transcription factor coordinating the oxidative 
stress response [35]. YAP1 is equivalent to the redox regulated mammalian Nrf2/Keap1/ARE  
system [36]. Detailed investigations to characterize the allicin-dependent redoxome are currently 
underway in our group. 
Scheme 3. Overview of redox chemistry of allicin and cellular thiols: Allicin (1) is able to 
react with cellular thiols like glutathione (GSH) and cysteine-containing proteins. Reaction 
with proteins leads to S-allyl-mercapto-proteins (2) and allyl sulfenic acid (3).  
S-allyl-mercapto-proteins are able to react with other proteins by formation of disulfide  
bond-stabilised complexes (4) or to form intramolecular disulfide bonds (5). Both reactions 
lead to elimination of allyl mercaptan (6). Protein disulfide bonds can be reduced by cellular 
GSH which leads to S-glutathionyl-mercapto-proteins (7). To remove the glutathionyl residues 
from the proteins another GSH is needed. Allicin also reacts with GSH. This reaction leads to 
S-allyl-mercapto-glutathione (8) and allyl sulfenic acid (3). S-allyl-mercapto-glutathione 
can undergo a thiol/disulfide exchange reaction with another GSH to form GSSG and allyl 
mercaptan (6). Allyl sulfenic acid (3), produced in direct reactions of allicin and thiols is 
able to react with proteins to form S-allyl-mercapto-proteins (2), with GSH to form  
S-allyl-mercapto-glutathione (8), with allyl mercaptan (6) to DADS (9) or with another 
allyl sulfenic acid (3) to form allicin again. 
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4. Antimicrobial Activity of Allicin 
Since ancient times mankind has had to face many different kinds of disease and there was much 
speculation about their causes. In the Middle Ages the devil turned out to be the usual suspect, 
however, in the 19th century Robert Koch proved that bacteria caused and transmitted anthrax and the 
Germ Theory of disease was born. Reports about the targeted use of garlic as an antimicrobial agent go 
back to the famous Louis Pasteur [37] and in World War I extracts of garlic were used in antibacterial 
and antiseptic therapeutics. Numerous scientific studies concerning the antibacterial potential of garlic 
have been published (for a detailed list of reports, refer to Koch and Lawson [5]). 
4.1. Allicin Is almost Exclusively Responsible for the Antimicrobial Activity of Freshly Crushed Garlic 
Isolation and testing of the organosulfur compounds from garlic for antimicrobial activity was 
carried out in the 1940s [9]. Neither DADS, directly formed by the decomposition of allicin, nor the 
diallylpolysulfanes showed any remarkable antimicrobial activity, unless used in very high 
concentrations. Koch and Lawson [5] determined the minimal concentration of organosulfur 
compounds found in crushed garlic needed to inhibit the growth of Escherichia coli and 
Staphylococcus aureus. According to their results, approximately 35× more DADS (6.15 mM) was 
needed to inhibit the growth of these two bacteria compared to allicin (0.17 mM). 
The fact that DADS, as one of allicin’s direct decomposition products, has a significantly lower 
antimicrobial activity indicates that the thiosulfinate-group (Scheme 2) plays an important role in that 
activity since it is lost during the reduction of allicin to DADS. Small et al. [38] considered 
thiosulfinates as “a new class of compounds of which the antibacterial agent of garlic [allicin] 
represents the prototype” and chemically synthesized different thiosulfinates, including allicin itself. 
The thiosulfinate derivatives differed in the alkyl groups that were attached to the thiosulfinate group 
in chain length as well as in branching. They tested these on twenty different bacterial isolates by 
elucidating the minimal concentration needed for a bacteriostatic effect in liquid culture. Thereby, two 
general observations could be made: Firstly, branching of the alkyl groups resulted in a lowered 
activity. For example, two times more isopropyl thiosulfinate derivative (effective concentrations 
ranging from 10 to >1200 µM) is needed for a bacteriostatic effect than of the n-propyl thiosulfinate 
derivative (ranging from 10 to 600 µM). Of all the derivatives tested, the most branched alkyl group 
attached to the thiosulfinate, tert-butyl-ethyl thiosulfinate, showed the weakest activity of all 
thiosulfinates (ranging from 60 to >1200 µM). The most effective thiosulfinate turned out to be  
n-pentyl-thiolsulfinate (ranging from 0.7 to 130 µM) which was slightly more effective than allicin 
(ranging from 50 to 150 µM) and furthermore, it was much more stable than allicin due to the lack of 
double bonds. Secondly, the bacteriostatic effect of thiosulfinates against Gram positive bacteria 
became stronger with increasing carbon chain length but weaker against Gram negative bacteria. 
Depending on the organism and the antibiotic used, on a mol-for-mol basis the effectivity of 
conventional antibiotics like β-lactams (penicillin and derivatives like ampicillin) or glycosidic 
antibiotics like kanamycin are comparable to allicin [9,39,40] (Figure 1). However, allicin is active 
against a broader spectrum of microorganisms than most of the commonly used antibiotics. For 
example, allicin is active against both Gram positive and Gram negative bacteria, whereas penicillin is 
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practically not effective against the latter [9]. Allicin is also active against human pathogens that are 
resistant against certain antibiotics. A prominent case of such a germ is methicillin resistant 
Staphylococcus aureus (MRSA)—the chief culprit in many hospital infections. It has been shown that 
this important pathogen is effectively inhibited by allicin [41]. 
Figure 1. Plate diffusion test. Antibacterial activity against E. coli DH5α demonstrated on 
seeded agar plates by different antibiotics is indicated by clear zones where growth 
inhibition has occurred. Freshly grown E. coli cells (OD600 = 0.2, 300 µL) were embedded 
in 20 mL warm agar in a Petri dish (diameter 9 cm). Afterwards, holes (diameter 0.6 cm) 
were punched out and filled with 40 µL of antibiotic solution at the mM concentrations 
indicated. Pictures were taken after 24 h of incubation in the presence of the antibiotics. 
(A) kanamycin; (B) allicin; and (C) ampicillin.  
 
In several case studies the antimicrobial activity of allicin has been investigated by using garlic 
extract rather than pure allicin. In general, the antimicrobial activity of garlic extract correlates with the 
allicin content [42], and if the formation of allicin is inhibited during extraction [12], or if allicin is 
removed [43], the extract loses its antimicrobial activity. However, Fujisawa et al. [40] demonstrated 
that on a mol-for-mol basis, an allicin-containing extract of garlic was twice as effective as synthetic 
allicin in inhibiting Staphylococcus aureus. These findings indicate either synergistic effects of allicin 
with other components in the extract, or the additional action of other antimicrobial compounds. Thus, 
in every case study of allicin activity, the source of allicin (preferably pure allicin) should be taken into 
consideration. Some bacteria that were tested with either garlic extract and/or pure allicin are listed in 
Table 1. 
4.2. A Closer Look at the Basis for Antimicrobial Activity of Allicin 
After it was clearly shown by Cavallito and Bailey [9] that allicin is almost exclusively responsible for 
the antibiotic properties of garlic, the question of the mechanism of allicin’s antibiotic activity arose.  
The fact that a compound possesses antimicrobial activity is based on two principal features. Firstly, 
the compound must be able to reach potential targets and, if these are intracellular, that means it must 
be able to get inside the microbial cell. In the case of bacteria, an antibiotic has to penetrate the 
bacterial cell wall and the cell membrane. In addition to these two boundaries, the slime layers or 
capsules of certain bacteria can constitute an extra layer of resistance [44]. Following the arrival of the 
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antibiotic in the cell, it must have a target that, if attacked, leads to cell inactivity or cell death.  
Miron et al. [45] investigated the permeability of artificial and natural phospholipid membranes to 
allicin and demonstrated that allicin readily diffuses across these membranes. 
Table 1. Examples of allicin’s antibacterial activity.  
Bacteria Source of Allicin Amount of Allicin 
Experimental 
System a,b,c,d 
Reference 
Gram positive 
Bacillus spp. 
pure allicin extracted 
from garlic 
80 µM a [9] 
synthetic 30–150 µM a [38] 
Streptococcus spp. 
pure allicin extracted 
from garlic 
80 µM a [9] 
synthetic 
ranging from 60 µM  
to 200 µM 
a [38] 
methicillin sensitive Staphylococcus 
aureus NBRC 12732 
synthetic and  
garlic extract 
2.2 × 10−3–0.92 µmol b, c [40] 
methicillin resistant Staphylococcus 
aureus (clinical isolates) 
garlic extract 0.04–0.62 µmol b, e [41] 
Gram negative 
Salmonella typhimurium 
pure allicin extracted 
from garlic 
80 µM a [9] 
enzymatically 
synthesized from alliin 
ranging from 200 µM 
to 500 µM 
a [46] 
Agrobacterium tumefaciens garlic extract 1.72 µmol b, d [39] 
Escherichia coli K12 garlic extract 0.52–1.72 µmol b, c [39] 
Pseudomonas syringae  
(various pathovars) 
garlic extract 1.72 µmol b, d [39] 
Vibrio cholerae 
pure allicin extracted 
from garlic 
80 µM a [9] 
a complete growth inhibition in liquid culture; b growth inhibition zones; c via soaked filter discs on top of the 
seeded agar, d directly pipetted onto bacteria-seeded agar or e pipetted into wells punched out of the agar. 
When allicin is inside the cell, the antibiotic efficiency depends upon reaching and reacting with its 
targets and on the importance of those targets to the cell. In a seminal study, using logic that has stood 
the test of time, Cavallito and coworkers investigated the chemistry of several plant-derived 
antimicrobial compounds. It was found that the active principles of Allium sativum, Erythronium 
americanum, Asarum reflexum, Arctium minus, Ranunculus acris, Ranunculus bulbosus and of 
Brassica species as well as the non-plant-derived antibiotics penicillin, citrinin, gliotoxin, clavacin and 
pyocyanines react with cysteine. Pretreatment of these antibiotics with cysteine led to a total loss of 
activity against bacteria [47]. The different antibiotics were categorized into groups depending on their 
reactivity with cysteine residues [48]. The antibiotics were tested with cysteine residues that differed in 
their chemical microenvironment. In summary, certain antibiotics (group I, e.g., allicin) reacted with 
every cysteine residue independently of the neighbouring groups, as long as the –SH-group was freely 
available. Another group of antibiotics (group III, e.g., penicillin) showed increased reaction kinetics 
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with cysteine if other amino-groups were adjacent to the cysteine residue, but much slower reaction 
kinetics if not. Pyocyanines (group II antibiotics) turned out to be in between, since they showed 
intermediate reaction kinetics with the cysteines tested. These experiments were prophetically 
significant considering the present state of knowledge on the effects of surrounding amino acids on the 
micro pKa values (and therefore reactivity) of cysteine residues in proteins to oxidation [25,49]. 
Furthermore, Cavallito’s group speculated that the lower efficiency of allicin compared to penicillin 
and other antibiotics could be explained depending on their reactivity with cysteine residues. Since 
allicin reacts readily with all free cysteine residues available, it is buffered by proteins and low 
molecular weight thiols, independently of their importance for cellular viability. On the other hand, it was 
speculated that the specificity of penicillin for cysteine residues in the vicinity of amino-groups would lead 
to less waste of penicillin on unimportant targets, therefore making it more efficient than allicin [48]. 
Several case studies have subsequently reported the reactivity of allicin with thiol-containing  
enzymes [49–51]. For example, Wills [52] used allicin to inhibit the activity of several enzymes  
in vitro. Among them were important enzymes for primary metabolism like succinic dehydrogenase, 
hexokinase, triosephosphate dehydrogenase or alcohol dehydrogenase. 
But it has to be stated that some enzymes which did not contain a thiol group were also inhibited by 
allicin, whereas a few enzymes containing a thiol group could not. These findings suggest that not only 
cysteine is a potential target for allicin. The fact that some enzymes, although containing thiol groups, 
are not inactivated by allicin could be explained by an adverse pKa of these cysteines which depends 
on the microenvironment within the protein [49], so that the reactivity of these cysteines with allicin is 
very weak. Rabinkov et al. [51] investigated the reaction of cysteine with allicin using RP-HPLC and  
NMR-analysis of the resulting products. It was shown that allicin reacted with the sulfhydryl-group of 
cysteine via a disulfide exchange-like reaction (Figure 2B, unstressed situation shown in Figure 2A). 
By demonstrating that enzymes that are irreversibly inhibited by allicin can be rescued by strong 
reductants, the idea of the disulfide exchange-like reaction was transferred to a working model of 
enzyme inhibition by allicin via the same mechanism. 
4.3. Does Allicin have an Effect on DNA-, RNA- and Protein Synthesis? 
In 1988, Feldberg et al. investigated the effect of allicin on the synthesis of DNA, RNA and 
proteins in Salmonella typhimurium [46]. Here, it was determined that the minimal concentration of 
allicin needed to inhibit the growth of S. typhimurium was 0.3 mM. This allicin concentration turned 
out to be not lethal, so that S. typhimurium recovered and started to grow again at a lower rate, after a  
lag-period of fifty minutes. He measured the uptake of [3H] labeled uridine, leucine and thymidine in 
allicin-stressed and unstressed control cells and observed a maximum decrease of 68% for  
[3H]-thymidine uptake, a 65% decrease in [3H]-leucine uptake and a 100% decrease in [3H]-uracil 
uptake a few minutes after allicin had been applied to the bacteria. Since all these [3H] labeled 
molecules are building blocks for DNA (thymidine)-, RNA (uracil)- and protein (leucine) synthesis, 
Feldberg concluded that allicin affected the synthesis of these macromolecules, since there seemed to 
be no demand for the uptake of their precursors. In his study, however, the possibility that proteins 
involved in the uptake of these precursors could have been affected directly or indirectly was not 
investigated. For example, transport proteins could have been directly poisoned if they would have an 
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exposed cysteine group that could be affected by allicin. Indirectly, another possibility could be that 
the energy supply for the transport proteins was not met because enzymes in metabolic pathways had 
been affected by allicin treatment. Unfortunately, there was no follow-up investigation on these 
findings, so it remains unclear if the effect observed really showed a direct decrease in DNA-,  
RNA- and protein synthesis. 
Figure 2. Possible influence of allicin on proteins and protein synthesis. (A) protein 
synthesis in unstressed conditions. After translation the protein is folded into its final 
structure. (B) The cysteine residue that is accessible for attack (indicated in red) reacts with 
allicin via a disulfide exchange-reaction. The cysteine residue that is sterically blocked 
(indicated in blue) does not react with allicin. (C) According to Cavallito’s hypothesis, 
allicin may attack cysteine residues on elongating amino acid chains while the protein is still 
being synthesized and is not fully developed [48]. In this early stage, cysteine residues that are 
normally blocked for reactions with allicin (compare B) are now potential targets. Possible 
results may be an abortion of translation or misfolded proteins with reduced or no function.  
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4.4. Effect of Allicin on Fungi 
In the course of evolutionary time garlic plants developed the alliin/alliinase system, responsible for 
the production of allicin in freshly injured tissue, as a chemical weapon against biotic enemies. Since 
allicin is produced from a preformed substrate, without further expenditure of cellular energy or 
metabolism (i.e., passively), upon an attack by a pathogenic microbe or feeding animal, it belongs to 
the class of so called “phytoanticipins” [53]. In contrast, defence compounds that are produced by a 
plant de novo after an attack, dependent upon the expenditure of cellular energy and usually de novo 
gene expression (i.e., actively), are called phytoalexins (ibid). Besides bacteria, many fungal species 
are potential pathogens that the plant has to cope with. 
Beyond its well documented strong antibacterial properties allicin also shows toxic effects towards 
fungal cells and is able to inhibit spore germination and hyphal growth in vivo and in vitro [39]. Some 
efforts have been made to utilize this activity and develop allicin for application in medical therapy 
and agricultural plant protection [1,54,55]. 
Allicin showed promising activity both in vitro and in vivo against many plant-pathogenic fungal 
species, including pests, which are of economic importance. For example, Botrytis cinerea, 
Plectospherella cucumerina, Alternaria brassicicola and Magnaporthe grisea were strongly inhibited 
in vitro by allicin in fresh garlic juice in a plate-diffusion assay using spore-seeded agar [39]. In further 
studies, seed-disinfection turned out to be an efficient and potential application of allicin. It was shown 
that carrot seeds, infected with Alternaria spp., were disinfected by treatment with garlic juice in a 
degree comparable to a commercial seed-disinfection product [1]. In another assay, germination and 
seedling-development of pathogen-infested wheat seeds were enhanced by treatment with garlic juice [56]. 
Thus, allicin seems to have a potential in seed-disinfection programmes both in ecological agriculture 
and under low-tech conditions (like in developing countries). Since allicin is easy to obtain from 
freshly damaged garlic tissue, applications in that direction would allow a plant-protection strategy 
according to the maxim “grow your own pesticide”.  
Beside this agriculture-orientated application, fungal infections of humans and animals are a focus 
of interest [57]. Thus, it was claimed that allicin might be the basis of a strategy to treat aspergillosis in 
the lung, since allicin is highly volatile and thus can be delivered to the lung by inspiration [58]. 
Allicin can also easily be applied topically to fungal infections of the skin and hence attempts were 
made to use allicin in the therapy of Candida-infections. Interestingly, allicin’s activity was 
comparable to the frequently used antimycotic agent fluconazole [55]. There is an emerging interest in 
understanding the molecular basis of allicin’s fungicidal properties.  
Various studies of allicin’s effect on baker’s yeast show that it acts synergistically with other, 
known fungitoxic substances like copper [59–62]. Furthermore, synergistic toxicity of allicin with 
amphotericin B suggest an impact of allicin possibly on fungal plasma membrane [63–65]. 
A form of programmed cell death called apoptosis, where cells employ a genetic suicide 
programme, has been known for many years in multicellular organisms where it is employed in tissue 
turn-over and avoids inflammation responses which would usually occur when cells are damaged. 
Many stimuli can push cells into the apoptotic cell death programme, among others, oxidative stress. 
Using yeast as a model for apoptosis is a relatively new development, nevertheless, similarities to 
apoptotic processes in animal cells justify the transferability of the “apoptosis” term from animals to 
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yeast [66]. It was shown that allicin causes an oxidation of glutathione that results in a shift of the 
cellular redox-potential to a range correlating, according to Schafer and Buettner [67], with the 
induction of apoptosis [68]. Using both cytological, biochemical and genetic assays confirmed that 
allicin pushes yeast cells into apoptosis via the “oxidative route” [69].  
The global effects of allicin on the yeast transcriptome were reported by Yu et al. [69]. From  
micro-array experiments it was determined that allicin impaired the expression of genes coding for 
enzymes of amino acid metabolism (methionine, in particular), iron-uptake, the respiratory chain,  
thiamine-metabolism and proteasomal protein degradation [69]. The authors postulated that these 
results might be explained by the action of allicin on several different yeast transcription factors 
(YAP1, MSN2/4, RPN4, SKN7) (ibid.).  
In summary, allicin shows a broad spectrum of effects on a variety of fungal species which makes a 
possible application of allicin in medicinal therapy and agriculture an attractive possibility. On the 
basis of allicin’s effects on S. cerevisiae, it is apparent that the redox-effect of allicin seems to be a 
central, but not exclusive explanation of allicin’s fungicidal activity.  
5. Allicin’s Effects on Animal and Human Cells 
The variety of physiological effects makes allicin important for medicinal applications. Indeed, 
garlic has been used for centuries because of its therapeutic and health-promoting properties [4]. 
Studies have linked garlic consumption and the inclusion of garlic oils in the diet with such  
health-promoting benefits as the selective reduction of triacylglycerol, total- and LDL-cholesterol 
concentrations without any alteration in HDL-cholesterol levels [70–72]. Epidemiological evidence 
positively correlating garlic consumption with a reduction in the incidence of various types of cancers 
also abounds [73,74]. The finding that garlic powder has no effect on blood cholesterol level has been 
reasonably attributed to a possible loss of garlic’s biologically active components, particularly allicin, 
during preparation [75]. The presence in crushed garlic of various biologically active (degradation) 
compounds such as polysulfanes and the vinyldithiins, mean that not all health-promoting activities in 
crude preparations can be unequivocally ascribed to allicin directly. Our focus here will be restricted to 
only those health-promoting benefits that have been unequivocally demonstrated to be due to allicin’s 
specific and direct involvement.  
5.1. Allicin and Cardiovascular Diseases 
Cardiovascular disorders are complex, since they are influenced by different factors. 
Epidemiological studies unearth more and more variables that contribute to the development of 
cardiovascular problems to different extents [76]. In particular, general oxidative events like the 
oxidation of the low-density lipid protein (LDL) correlate frequently with atherosclerosis [77]. 
Although allicin is chemically an oxidant, it acts in lower doses as antioxidant at the physiological 
level [78]. This observation can be explained by the fact that mild oxidative conditions induce the 
expression of so-called phase II detoxifying enzymes, for instance by the activation of redox-sensitive 
transcription factors and build up protection against further and stronger oxidative insults.  
One example for the oxidation of a redox-sensitive transcription factor by the electrophile allicin is 
the Nrf2/Keap1 system that regulates the expression of various anti-oxidative enzymes (among others 
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of glutathione-biosynthesis). The fact that allicin can induce the Nrf2/Keap1 system has been shown in 
various studies [79,80]. It needs to be mentioned that the activation of Nrf2 by allicin is not only 
important in the context of cardiovascular diseases, but also for various other health related events like 
neurodegenerative diseases. In that context it was shown that allicin attenuates age-related cognitive 
and memory deficits by activating the Nrf2-system [80]. 
According to the so-called “LDL-receptor hypothesis” cholesterol is central for atherosclerosis [81], 
possibly due to the attraction and activation of macrophages by oxidized LDL, subsequently causing 
plaques in the arteries. Hence, cholesterol is assumed to be a risk-factor for atherosclerosis and thus for 
ischaemic disorders like Angina pectoris, cardiac infarction or stroke. One strategy, to interfere with a 
progression of plaque deposition in arteries is the reduction of the endogenous cholesterol-biosynthesis, 
commonly by application of statins [82]. While statins in the classical way competitively inhibit the 
enzyme 3-hydroxy-3-methylglutaryl-coenzyme-A-reductase (HMG-CoA reductase), allicin also shows 
the ability to suppress cholesterol biosynthesis [83,84], which is ascribed to the inhibition of the 
squalene-monooxygenase [85] and acetyl-CoA synthetase [50] enzymes. Furthermore, because 
coenzyme A contains a thiol-group, one can assume that allicin reacts with non-acetylated CoA directly, 
with the consequence that CoA is not available for biosynthetic processes. This would reduce the 
biosynthetic rates of CoA-dependent pathways (including sterol-biosynthesis) in a concentration-dependent 
manner. However, to our knowledge, this thioallylation of CoA has not yet been demonstrated. The 
different effects of allicin on cholesterol-biosynthesis are summarized in Scheme 4. 
Scheme 4. Impact of allicin on cholesterol-metabolism: Allicin was shown to inhibit two 
important enzymes of the cholesterol-biosynthesis pathway. On the one hand, Gupta and 
Porter [85] showed that allicin inhibits the squalene-monooxygenase while Focke and 
coworkers [50] demonstrated an inhibition of acetyl-CoA synthetase, a very early (and thus 
unspecific) step in cholesterol-biosynthesis. According to its chemistry, one can assume a 
direct reaction of allicin with the thiol-group of coenzyme A. 
 
A further important factor of cardiovascular disorders is platelet-aggregation, which is also 
important for ischemia of the heart and the brain. Platelet-aggregation is a complex biochemical 
process. Its prerequisite is the activation of the GPIIb/IIIa receptor by thromboxane A2 which causes 
the binding of, among others, fibrinogen [86]. Classical platelet-aggregation-inhibitors like  
acetyl-salicylic acid (aspirin) inhibit endogenous thromboxane-biosynthesis and thus the GPIIb/IIIa 
receptor activation. Interestingly, thiosulfinates like allicin are potent platelet-aggregation inhibitors. 
While a final concentration of 0.4 mM allicin inhibits platelet aggregation to about 90%, a comparable 
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concentration of 0.36 mM aspirin shows less than half this activity (~35% inhibition) [87].  
A last, but not minor impact of allicin on factors contributing to cardiovascular diseases is 
hypertension. Allicin acts as an antihypertensive and the reason, again, can be found in allicin’s reactivity. 
Since allicin decomposes rapidly to its degradation products, it has been shown that a complex reaction 
cascade with thiols (glutathione in particular) results in the release of hydrogen sulfide (H2S) [88] H2S, 
again, is a known potent gaseous signalling molecule in regard to blood-pressure regulation [89]. H2S 
lowers the blood pressure by relaxation of smooth-muscle cells surrounding the blood vessel that can 
expand and thus results in a lower blood pressure [88]. 
Taken together, it can be concluded that allicin counteracts cardiovascular diseases in various ways. 
Because of the high epidemiological impact and prevalence of cardiovascular diseases [90] and due to 
the fact that allicin is a component of fresh garlic in food [4], allicin and its follow-on products are of 
great interest influencing cardio-vascular disorders. Although, some aspects are already understood, 
further efforts are necessary to understand in more detail the molecular basis of allicin’s action. 
Epidemiological studies addressing the question how the uptake of allicin (or fresh garlic in its natural 
form) is beneficial for health would also be important.  
5.2. Allicin’s Immune-Modulatory Activity 
Allicin is a strong antimicrobial agent (see above) and is thus, at least in vitro, a potent antibiotic. 
Besides this direct impact on pathogens, a further facet of its activity is the influence on the 
endogenous immune system. If allicin is able to affect immune-correlated signalling pathways in cells, 
new possibilities for therapeutic development might be realized: In the case that allicin stimulates the 
activity of immune cells, this should result in a strengthened defence against pathogens, and 
suppression of immune processes might be of interest in regard to allergy or auto-immune disorders.  
In the meantime a plethora of evidence exists suggesting that allicin indeed acts on various  
immune-correlated processes.  
The initial observation was that allicin inhibits the migration of neutrophilic granulocytes into 
epithelia, which is a crucial process during inflammation [91]. Anti-inflammatory effects in a general 
sense have, indeed, been observed, e.g., in the mouse-model of Morbus Bechterew, a degenerative 
rheumatoid disease of the vertebral body [92]. Furthermore, allicin acts on T-cell lymphocytes by 
inhibition of the SDF1α-chemokine-induced chemotaxis and this effect is correlated with an impaired 
dynamic of the actin-cytoskeleton [93]. Finally, it has been shown that allicin inhibits the 
transendothelial migration of neutrophils (ibid.). It should be mentioned that allicin has been shown to 
have effects on the cytoskeleton in different biological systems. For example, it has been shown in 
mouse fibroblasts (NIH-3T3) that allicin causes a depolymerisation of the tubulin-cytoskeleton within 
minutes at a low concentration (2 µM), while with this concentration the actin cytoskeleton  
remained unaffected [94]. A key player in the activation of lymphocytes is the p21ras protein which 
triggers the inactivation of the RAS-GTPase by enhancing its enzymatic activity [95]. Interestingly, 
p21ras appears to be a direct target of allicin since it seems to be thioallylated by allicin and thus 
activated [96] and, subsequently, this activation might result in an enhanced phosphorylation of the 
ERK1/2 kinase (ibid.), an important MAP-kinase involved in different signalling pathways (Scheme 5). 
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Scheme 5. Allicin stimulates lymphocytes by affecting p21ras: Thioallylation that means 
the binding of an allyl sulfenic acid to the thiol of cysteine118 leads to an activation of 
p21ras and subsequently to stimulation of ERK1/2 phosphorylation. These processes are 
crucial for the activation of lymphocytes.  
 
Another central regulator of a coordinated immune-response is the TNFα cytokine [97]. Impairment 
of TNFα secretion massively influences the regulation of the immune-response. For that reason it is 
interesting that allicin inhibits the release of TNFα-dependent pro-inflammatory cytokines in intestinal 
epithelia [98]. This, however, reflects an effect of allicin on factors downstream of TNFα. Since TNFα is 
mainly secreted by macrophages [99], the effect of allicin on macrophages was examined with respect to 
how allicin influences the expression of TNFα itself. It is interesting that a stimulation of macrophages 
by lipopolysaccharide (LPS) after a pre-incubation in the presence of allicin enhances the activity of the 
TNFα promoter, suggesting a TNFα-triggering role for allicin in LPS-stimulated cells [100]. 
Furthermore, allicin inhibits phosphatase-activity, correlating with an enhanced phosphorylation of 
ERK1/2 (ibid.), which is a central component of the signalling cascade transferring extracellular 
signals into intracellular signalling cascades. Furthermore, the release of Reactive Nitrogen Species 
(RNS) by LPS-stimulated macrophages was suppressed by allicin [100,101]. 
It is fascinating if allicin could influence inflammation both directly by exerting an antimicrobial 
effect and by altering immune-cell signalling. It will be informative to study further the effects of 
allicin on immune cells on a molecular level and, systematically, it’s impact on the development of 
inflammatory processes and disease.  
5.3. Allicin and Cancer 
There is a link between the functioning of the immune system and cancer. In an early study (1960), 
explants of mouse-tumours were incubated in allicin before implantation into healthy mice. In contrast 
to the control group (where the explants were not allicin-treated), mice with tumour explants incubated 
in allicin showed no further growth of the explant [102]. 
How allicin affects cancer cells has been examined at the molecular level. It became clear that the 
induction of apoptosis was crucial for the anti-cancer effect of allicin. As discussed in the yeast system 
(see above), allicin also causes a redox-shift in human cell cultures [103]. This leads to the execution 
of cell death, both in a caspase-dependent [104] and caspase-independent manner [105]. Beside 
caspase activity, the apoptosis inducing factor (AIF), which contributes to the apoptotic  
DNA-laddering, is involved in allicin-induced cell death (ibid.).  
Bat-Chen and co-workers, for instance, showed that Nrf2 is involved in allicin-induced apoptosis [106]. 
This reveals the “Janus face” of Nrf2 [107]: While Nrf2 is mostly described as an anti-apoptotic factor 
regulating the expression of anti-apoptotic proteins of the Bcl-2 family like Bcl-2 and  
Bcl-xL [108,109], Nrf2 also seems to have a pro-apoptotic function under certain circumstances 
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(ibid.). Also the ERK1/2 map kinases were shown to be influenced by allicin in immune cells; these 
kinases are also important for apoptosis induction by allicin [103,110].  
Although this paragraph gives only a brief overview about the impact of allicin on cancer cells, 
some major factors targeted by allicin can be outlined. One problem exacerbating a clinical application 
of allicin is its chemical instability. As soon allicin is taken up by the body, or at the latest in the 
circulatory system, it will react with accessible thiols and in particular with the high amount of glutathione 
and also be decomposed to other compounds. This makes an application as a pharmaceutical at the 
moment unlikely. However, the potential for using garlic in a nutriceutical context, with health 
benefits not only for cancer prevention or therapy, but also for the other medical areas mentioned here, 
remains an attractive possibility. A sophisticated attempt to circumvent the stability problem is a 
coupling of alliinase to a delivery system and supplying the stable substrate alliin, thus allowing 
production of allicin in situ at the position of the particular epitope. In this regard, attaching alliinase 
via antibodies against cancer cells successfully showed a promising proof-of principle [111].  
6. Effects of Allicin on Plants  
Effects on Germination, Root Growth and Viability on Arabidopsis thaliana 
Having already discussed allicin’s effects on bacteria, fungi and animal systems in this review it 
remains to comment on the effects of allicin on plant physiology. In our lab we investigated the effects 
of allicin treatment on different developmental stages of the model plant Arabidopsis thaliana. The 
effect of increasing allicin concentrations on the development of Arabidopsis (accession Col-0) 
seedlings was monitored. 
Two morphological effects could be seen by the naked eye (Figure 3). Firstly, exposure to allicin 
correlated with a decrease in primary root elongation in a concentration-dependent manner and the 
minimal allicin concentration needed to inhibit root elongation completely was determined to be 75 µM 
allicin (Figure 4). The fact that the root growth is inhibited by allicin without killing the whole plant 
indicates that root functions like the uptake of water and nutrients are presumably still operational. 
Secondly, exposure to a much higher concentration (500 µM allicin) led to bleaching of the 
seedlings (Figure 5). 
Because allicin is an efficient thiol reagent, we reasoned that a plant with reduced amounts of GSH 
should be more severely affected in the inhibition of seed germination and primary root growth than 
wild type (wt) plants. Therefore, we tested the A. thaliana phytoalexin deficient 2-1 (pad2-1) mutant 
(Col-0 background), which only has approximately 20% of normal GSH levels due to a mutation in the 
gene coding for the enzyme glutamate cysteine ligase (GCL, Figure 6A) [112]. Seed-germination of 
the pad2-1 mutant was found to be approximately 3× more sensitive to allicin than the wt and primary 
root growth was also inhibited at lower allicin concentrations than in the wt (data not shown). The 
greater sensitivity of the GSH-deficient pad2-1 mutant is in accordance with earlier studies of in vitro 
enzyme inhibition by allicin [51,52,113]. Enzyme inhibition by allicin could be competed out by 
incorporation of cysteine or GSH into the reaction buffer and post-incubation with GSH led to a 
reversal of the inhibition for most (but not all) enzymes (ibid.). Although the enzyme inhibition studies 
were done in vitro, GSH is the most important and most abundant redox buffer in vivo in most 
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eucaryotic and procaryotic cells [67], lending support to the idea that GSH is a protective agent against 
allicin in vivo.  
Figure 3. Effect of allicin on seedling development: A. thaliana (Col-0) wild type 48 h 
after allicin treatment. In this experiment, seeds were set on sterile filter papers which were 
placed on Murashige & Skoog (MS) medium. After stratification at 4 °C for 48 h, 
germination and growth took place with the Petri plates tilted to an angle of approx. 20° 
from vertical to ensure unidirectional root growth according to root gravitropism. After 
three days of cultivation, filter papers were transferred to MS media that contained 
different amounts of allicin. Pictures were taken 48 h after treatment. For the sake of clarity 
only a small representative fraction of seedlings is shown for relevant concentrations. 
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Figure 4. Effect of allicin on elongation of primary root growth: To investigate the effects 
of allicin on A. thaliana seedlings (accession Col-0), seeds were sown onto sterile filter 
paper which had been placed on Murashige & Skoog (MS) medium beforehand. After 
stratification (4 °C, 48 h), the Petri plates were cultivated at an angle approx. 20° from 
vertical to ensure unidirectional gravitropic root growth. For allicin exposure, the filter 
papers were transferred onto allicin-containing medium and 48 h after further cultivation, 
pictures were taken and the root lengths were measured using the software ImageJ [114]. 
The “boxplot” was prepared with the program PAST [115]; every dot represents the 
measurement of one root. The two halves of one box represent the 25 and 75 percent 
quartile, while the horizontal line in the middle shows the median. n = total number of 
measurements for the given treatment.  
 
Figure 5. Allicin causes bleaching of seedlings: Sterile filter papers were placed on 
Murashige & Skoog (MS) medium and were sown with Col-0 A. thaliana wild type seeds. 
Following stratification (4 °C, 48 h), seeds were allowed to germinate and grow for three 
days. For allicin treatment, the filter papers were transferred onto MS medium containing 
different amounts of allicin. Effects on the seedlings were recorded 48 h after allicin 
treatment. Bleached seedlings showed either partial or complete bleaching, whereas green 
seedlings showed no signs of bleaching.  
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Besides the fact that GSH can reduce disulfides back to thiols (Scheme 3), glutathiolation of 
accessible thiol groups can protect against their over-oxidation to sulfinic and sulfonic acids [23] 
(Figure 6B). As already discussed above, GSH is known to buffer the redox state of the cell [67]. Since 
it has been demonstrated that allicin also can shift the cell’s redox potential by oxidizing the 
glutathione pool, and push cells into apoptosis [68], the importance of GSH levels in cellular 
protection against allicin becomes doubly clear. 
Figure 6. Glutathione biosynthesis and function: (A) Cysteine and glutamate are 
enzymatically linked to γ-glutamylcysteine via the action of glutamate cysteine ligase (GCL). 
The next step in synthesis is the formation of glutathione itself from cysteine and  
γ-glutamylcysteine via glutathione synthetase (GS). (B) Glutathione can be oxidized to 
glutathione dimers (GSSG) and thereby serves to buffer oxidants within the cell. A shift in 
the equilibrium from GSH towards a higher proportion of GSSG may promote the 
glutathiolation of free cysteines on protein surfaces, thus shielding these cysteine residues 
during oxidative stress conditions from over-oxidation. Illustration was redrawn from [116].  
 
7. Conclusions 
Allicin is a natural product which is consumed widely in most cultures that employ garlic in their 
diet. It is a physiologically active molecule with many potential health benefits. Furthermore, its 
potential for development in human and veterinary medicine is great and the concept of farmers being 
able to “grow their own” plant protection in an environmentally friendly manner is attractive, 
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particularly in subsistence agriculture where the cost of commercial preparations may be prohibitive. 
This review, hopefully, will help to bring some of the scientific literature on the effects of allicin to the 
attention of interested scientists who may then further contribute to our understanding of this 
fascinating molecule. 
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